MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$1,476,335K
Cash and cash
equivalents
$260,843K
Prepaid expenses and
other current assets
$76,310K
Long-term investments
$1,004,017K
Property and equipment,
net
$260,695K
Other assets
$155,539K
Operating lease
right-of-use assets
$113,103K
Restricted cash
$1,466K
Total current assets
$1,813,488K
Total noncurrent
assets
$1,534,820K
Total assets
$3,348,308K
Total liabilities and
stockholders' equity
$3,348,308K
Total stockholders'
equity
$2,996,014K
Total liabilities
$352,294K
Accumulated deficit
-$2,475,569K
Accumulated other
comprehensive loss
-$6,834K
Additional paid-in capital
$5,478,270K
Total current
liabilities
$242,082K
Operating lease
liabilities long-term
$110,212K
Common stock, 0.001 par
value 500,000,000...
$147K
Accrued contract
manufacturing expenses
$134,704K
Accounts payable
$63,060K
Accrued expenses
$30,247K
Accrued compensation
$7,986K
Operating lease
liabilities current
$6,085K
Back
Back
Balance Sheet
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX)
source: myfinsight.com